Innoblative is a medical device company whose mission is to develop innovative advanced energy medical devices.
Innoblative is developing Sira™, a Saline-assisted Intraoperative Radiofrequency Ablation device that uses bipolar current to intraoperatively create a controlled zone of ablation. Sira’s unique design and saline microinfusion system allow it to have unparalleled contact with target tissue and to be powered with existing electrosurgical generators already installed in the operating room. This device represents an exciting new option for intraoperative ablation of soft tissue which surgeons can easily adopt.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 22, 2017 | Grant | $680.65K | 1 | National Science Foundation | — | Detail |
Jun 24, 2016 | Grant | $225K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |